trial · primary record
VRT106
HCC
| Phase | Phase 2, Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 66 |
| Primary completion | 2029-06-30 |
| Primary endpoint | Incidence of Dose-Limiting Toxicities |
| Registry ID | NCT07589244 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:41:12.525Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07589244
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Vrt106 · compound